BFNH insider filings

BIOFORCE NANOSCIENCES HOLDINGS, INC. — 12 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-09-02. Screen BFNH transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 2 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Ferguson Merle — Director1—1 leg · 26,700,000 sh · $400,5002
KAISER RICHARD KAISER — CEO & CFO, Director1——3

Recent insider filings — BIOFORCE NANOSCIENCES HOLDINGS, INC.

FiledFormInsiderReported transactionsSource
2026-09-024Ferguson Merle — DirectorGift (G): 20,580,000 @ $0.01 · Gift (G): 4,132,000 @ $0.00 · Sale (S): 26,700,000 @ $0.01EDGAR
2026-09-024KAISER RICHARD KAISER — CEO & CFO, DirectorGift (G): 4,132,000 @ $0.00 · Other (J): 38,462 @ $0.65 · Grant/award (A): 316,909 @ $0.55EDGAR
2023-10-184Ferguson Merle — CEO, Director, 10% ownerGift (G): 1,470,000 @ $0 · Gift (G): 1,470,000 @ $0 · Gift (G): 1,400,000 @ $0EDGAR
2023-10-184Ferguson Merle — CEO, Director, 10% ownerGift (G): 500,000 @ $0EDGAR
2022-12-144Ferguson Merle — CEO, Director, 10% ownerGift (G): 20,000 @ $0EDGAR
2022-10-034Ferguson Merle — CEO, Director, 10% ownerGift (G): 10,000 @ $0EDGAR
2020-12-094/AKAISER RICHARD KAISER — CFO, Director, 10% ownerGrant/award (A): 3,000,000 @ $0.00 · Option exercise (M): 500,000 (derivative) @ $0.00EDGAR
2020-12-094/AFerguson Merle — CEO, Director, 10% ownerGrant/award (A): 11,000,000 @ $0.00 · Option exercise (M): 1,500,000 (derivative) @ $0.00EDGAR
2020-12-094/AKAISER RICHARD KAISER — CFO, Director, 10% ownerGrant/award (A): 3,000,000 @ $0.00 · Option exercise (M): 500,000 (derivative) @ $0.00EDGAR
2020-12-074KAISER RICHARD KAISER — CFO, Director, 10% ownerGrant/award (A): 3,000,000 @ $0.00 · Option exercise (M): 500,000 (derivative) @ $0.00EDGAR
2020-12-074/AKAISER RICHARD KAISER — CFO, Director, 10% ownerGrant/award (A): 3,000,000 @ $0.00 · Option exercise (M): 500,000 (derivative) @ $0.00EDGAR
2020-12-074/AFerguson Merle — CEO, Director, 10% ownerGrant/award (A): 11,000,000 @ $0.00 · Option exercise (M): 1,500,000 (derivative) @ $0.00EDGAR

Recent 8-K events — BIOFORCE NANOSCIENCES HOLDINGS, INC.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-10-078-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-048-K3.02 — Unregistered Sales of Equity SecuritiesEDGAR
2026-08-188-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-148-K8.01 — Other EventsEDGAR
2026-07-078-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-018-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-188-K5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2024-05-078-K4.01 — Changes in Registrant's Certifying Accountant
9.01 — Financial Statements and Exhibits
EDGAR
2021-11-308-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2021-06-028-K8.01 — Other EventsEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=BFNH returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs